Contact Information
Company Information
Company
MicuRx Pharmaceuticals, Inc.
Annual Revenue
12600000.0
Total Funding
245313316.0
Technologies
Outlook
Bootstrap Framework
Mobile Friendly
WordPress.org
Apache
Android
AI
Keywords
infectious diseases
biotechnology
life sciences
biotechnology research
biopharmaceutical
antibiotics
drug-resistant infections
innovative medicines
clinical trials
anti-infective drugs
bacterial resistance
renal cancer treatment
targeted therapy
drug development
clinical evaluation
phase iii trials
mrsa
vre
new drug application
clinical efficacy
antibacterial drugs
drug commercialization
multidrug-resistant bacteria
contezolid
mrx-4
mrx-5
mrx-8
treatment strategies
kidney disease
nephritis
antibiotic therapy
clinical research
drug discovery
therapeutic agents
toxicity reduction
pharmaceutical development
public health
metabolic diseases
pharmaceutical innovation
intellectual property
global health
antimicrobial resistance
pediatric patients
surgical resection
molecularly targeted therapy
chemotherapy
cancer immunotherapy
new antibiotic development
therapeutic efficacy
renal targeting
toxicity management
healthcare solutions
health care
health
wellness & fitness
hospital & health care
Get Full Contact Details
Subscribe to reveal email addresses and export contacts.
View Plans